61 – 70 of 111
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
- Contribution to journal › Article
- 2019
-
Mark
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study) : Protocol for a multicenter phase II open label study
- Contribution to journal › Article
-
Mark
A walk through tau therapeutic strategies
- Contribution to journal › Scientific review
-
Mark
Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics
- Contribution to journal › Article
-
Mark
Intravesical therapy - BCG and beyond
- Contribution to journal › Article
-
Mark
Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer : a comparative study of transurethral resection and cystectomy specimens
- Contribution to journal › Article
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
- Contribution to journal › Debate/Note/Editorial
- 2018
-
Mark
Targeting dendritic cells in pancreatic ductal adenocarcinoma
- Contribution to journal › Scientific review
-
Mark
Tumor Regression and Cure Depends on Sustained Th1 Responses
- Contribution to journal › Article
-
Mark
Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain
- Contribution to journal › Article
